QL
RCUS icon

Quarry LP’s Arcus Biosciences RCUS Stock Holding History

Quarry LP’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$925 Buy
+30
New +$741 ﹤0.01% 1995
2024
Q2 		– Sell
-2,750
Closed -$51.9K – 2044
2024
Q1 		$51.9K Buy
2,750
+1,750
+175% +$30.3K 0.01% 445
2023
Q4 		$19.1K Sell
1,000
-3,972
-80% -$63.5K ﹤0.01% 780
2023
Q3 		$89.2K Buy
+4,972
New +$99.9K 0.02% 220

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Quarry LP's RCUS Position: Q2 2026 in Review

Quarry LP opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 30 shares worth $925. The stake represents ﹤0.01% of the portfolio and ranks #1995 among its holdings. This is a return to the name: Quarry LP previously reported a position in RCUS as recently as Q1 2024.

Quarry LP first reported a position in RCUS in Q3 2023 and has held it in 4 quarters since. The position peaked at $89.2K in Q3 2023. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Quarry LP held 30 shares of Arcus Biosciences worth $925 as of Q2 2026.
  • Arcus Biosciences was a new Quarry LP position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1995 holding.
  • Quarry LP first reported a position in Arcus Biosciences in Q3 2023 and has held it in 4 quarters since.
  • Quarry LP's Arcus Biosciences position peaked at $89.2K in Q3 2023.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.